Novel Therapeutic Approaches of Ion Channels and Transporters in Cancer.

2区 医学 Q1 Biochemistry, Genetics and Molecular Biology
Ana Ramírez, Janice García-Quiroz, Luis Aguilar-Eslava, Yesennia Sánchez-Pérez, Javier Camacho
{"title":"Novel Therapeutic Approaches of Ion Channels and Transporters in Cancer.","authors":"Ana Ramírez,&nbsp;Janice García-Quiroz,&nbsp;Luis Aguilar-Eslava,&nbsp;Yesennia Sánchez-Pérez,&nbsp;Javier Camacho","doi":"10.1007/112_2020_28","DOIUrl":null,"url":null,"abstract":"<p><p>The expression and function of many ion channels and transporters in cancer cells display major differences in comparison to those from healthy cells. These differences provide the cancer cells with advantages for tumor development. Accordingly, targeting ion channels and transporters have beneficial anticancer effects including inhibition of cancer cell proliferation, migration, invasion, metastasis, tumor vascularization, and chemotherapy resistance, as well as promoting apoptosis. Some of the molecular mechanisms associating ion channels and transporters with cancer include the participation of oxidative stress, immune response, metabolic pathways, drug synergism, as well as noncanonical functions of ion channels. This diversity of mechanisms offers an exciting possibility to suggest novel and more effective therapeutic approaches to fight cancer. Here, we review and discuss most of the current knowledge suggesting novel therapeutic approaches for cancer therapy targeting ion channels and transporters. The role and regulation of ion channels and transporters in cancer provide a plethora of exceptional opportunities in drug design, as well as novel and promising therapeutic approaches that may be used for the benefit of cancer patients.</p>","PeriodicalId":21169,"journal":{"name":"Reviews of Physiology Biochemistry and Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/112_2020_28","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews of Physiology Biochemistry and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/112_2020_28","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 8

Abstract

The expression and function of many ion channels and transporters in cancer cells display major differences in comparison to those from healthy cells. These differences provide the cancer cells with advantages for tumor development. Accordingly, targeting ion channels and transporters have beneficial anticancer effects including inhibition of cancer cell proliferation, migration, invasion, metastasis, tumor vascularization, and chemotherapy resistance, as well as promoting apoptosis. Some of the molecular mechanisms associating ion channels and transporters with cancer include the participation of oxidative stress, immune response, metabolic pathways, drug synergism, as well as noncanonical functions of ion channels. This diversity of mechanisms offers an exciting possibility to suggest novel and more effective therapeutic approaches to fight cancer. Here, we review and discuss most of the current knowledge suggesting novel therapeutic approaches for cancer therapy targeting ion channels and transporters. The role and regulation of ion channels and transporters in cancer provide a plethora of exceptional opportunities in drug design, as well as novel and promising therapeutic approaches that may be used for the benefit of cancer patients.

离子通道和转运体治疗癌症的新途径。
与健康细胞相比,癌细胞中许多离子通道和转运体的表达和功能表现出重大差异。这些差异为癌细胞的发展提供了有利条件。因此,靶向离子通道和转运体具有良好的抗癌作用,包括抑制癌细胞的增殖、迁移、侵袭、转移、肿瘤血管化和化疗耐药,以及促进细胞凋亡。离子通道和转运体与癌症相关的一些分子机制包括氧化应激、免疫反应、代谢途径、药物协同作用以及离子通道的非规范功能。这种机制的多样性提供了一个令人兴奋的可能性,提出了新的和更有效的治疗方法来对抗癌症。在这里,我们回顾和讨论了目前大多数针对离子通道和转运体的癌症治疗的新方法。离子通道和转运体在癌症中的作用和调控为药物设计提供了大量的特殊机会,也为癌症患者提供了新的和有前途的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reviews of Physiology Biochemistry and Pharmacology
Reviews of Physiology Biochemistry and Pharmacology 医学-生化与分子生物学
CiteScore
11.40
自引率
0.00%
发文量
5
审稿时长
>12 weeks
期刊介绍: The highly successful Reviews of Physiology, Biochemistry and Pharmacology continue to offer high-quality, in-depth reviews covering the full range of modern physiology, biochemistry and pharmacology. Leading researchers are specially invited to provide a complete understanding of the key topics in these archetypal multidisciplinary fields. In a form immediately useful to scientists, this periodical aims to filter, highlight and review the latest developments in these rapidly advancing fields.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信